|
CHML expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.542230E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.518800E-01 |
| Normal-vs-Stage2 |
4.600400E-01 |
| Normal-vs-Stage3 |
8.222400E-03 |
| Normal-vs-Stage4 |
1.376560E-01 |
| Stage1-vs-Stage2 |
4.962000E-01 |
| Stage1-vs-Stage3 |
9.757100E-03 |
| Stage1-vs-Stage4 |
1.423230E-01 |
| Stage2-vs-Stage3 |
2.062600E-01 |
| Stage2-vs-Stage4 |
2.245600E-01 |
| Stage3-vs-Stage4 |
4.662000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.344210E-02 |
| Normal-vs-AfricanAmerican |
3.520000E-01 |
| Normal-vs-Asian |
5.632800E-01 |
| Caucasian-vs-AfricanAmerican |
4.748000E-01 |
| Caucasian-vs-Asian |
3.728200E-01 |
| AfricanAmerican-vs-Asian |
4.909400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.630000E-01 |
| Normal-vs-Female |
5.970700E-04 |
| Male-vs-Female |
5.515800E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.660420E-01 |
| Normal-vs-Extreme_Weight |
5.299400E-01 |
| Normal-vs-Obese |
3.984400E-03 |
| Normal-vs-Extreme_Obese |
9.645000E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.905900E-02 |
| Normal_Weight-vs-Obese |
3.172600E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.210400E-01 |
| Extreme_Weight-vs-Obese |
1.795910E-03 |
| Extreme_Weight-vs-Extreme_Obese |
7.482400E-01 |
| Obese-vs-Extreme_Obese |
2.279800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.426000E-02 |
| Normal-vs-Age(41-60Yrs) |
7.237500E-03 |
| Normal-vs-Age(61-80Yrs) |
4.567200E-01 |
| Normal-vs-Age(81-100Yrs) |
5.304200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.811810E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.206300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.188100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.366100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.140220E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.716000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.728800E-01 |
| Normal-VS-Type2 PRCC |
6.248600E-01 |
| Normal-VS-KIRP CIMP |
4.456900E-03 |
| Normal-VS-Unclassified PRCC |
2.050100E-02 |
| Type1 PRCC-VS-Type2 PRCC |
8.504200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
5.642900E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
5.766100E-02 |
| Type2 PRCC-VS-KIRP CIMP |
5.756100E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
1.309770E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.163900E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.325600E-01 |
| Normal-vs-N1 |
3.883000E-03 |
| Normal-vs-N2 |
3.000000E-01 |
| N0-vs-N1 |
4.739000E-03 |
| N0-vs-N2 |
2.481400E-01 |
| N1-vs-N2 |
4.381200E-01 |
|
|
